Die neuen Psychedelika: Eine Dosis, acht Stunden, ein Therapeut in Bereitschaft

*From Bloomberg News reporters Ashleigh Furlong and Tala Ahmadi*

The world of psychedelics is getting ready for the mainstream after toiling away for years to prove that some mood-altering compounds should be used for clinical treatment. British biotech company Compass Pathways Plc is gearing up for a 2027 launch based on synthetic psilocybin — the active compound in magic mushrooms.

Compass’ product targets people with treatment-resistant depression whose condition wasn’t improved by at least two other medicines, leaving them battling symptoms that could include anxiety and suicidal urges.

The treatment is very different from psilocybin’s alter ego as a hedonistic recreational drug. Patients must go to a clinic and speak to their therapist before swallowing a pill and lying down for as long as eight hours. Specially selected music plays through headphones, and a therapist is always at hand. One dose is enough for most people to start feeling better. The most common side effects are headaches and nausea.

[*Read more here*](https://www.bloomberg.com/news/articles/2025-12-26/psilocybin-aims-for-mainstream-as-a-psychedelic-treatment-for-depression)*.*

How much is an American doctor to babysit you for 8 hrs??